SCHEMBL16695822

SCHEMBL16695822

O=c1o[nH]c2ccc(Br)cc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIM1 P11309 3/20 0.50
▸ FLT3 P36888 3/20 0.50
▸ JAK2 O60674 2/20 0.50
▸ CHEK1 O14757 2/20 0.50
▸ PRKD3 O94806 2/20 0.50
▸ MAP4K4 O95819 2/20 0.50
▸ CSF1R P07333 2/20 0.50
▸ CLK2 P49760 2/20 0.50
▸ MAP4K2 Q12851 2/20 0.50
▸ DYRK1A Q13627 2/20 0.50
▸ NTRK3 Q16288 2/20 0.50
▸ AURKB Q96GD4 2/20 0.50
▸ CLK4 Q9HAZ1 2/20 0.50
▸ AURKA O14965 1/20 0.50
▸ DAPK3 O43293 1/20 0.50
▸ PAK4 O96013 1/20 0.50
▸ ABL1 P00519 1/20 0.50
▸ NTRK1 P04629 1/20 0.50
▸ RET P07949 1/20 0.50
▸ MET P08581 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6169043 0.84 METAP2 (0.50) PIM1FLT3JAK2CHEK1PRKD3
SCHEMBL29440610 0.73 MAOA (0.61) PIM1FLT3JAK2CHEK1PRKD3
SCHEMBL389647 0.73 MAOA (0.61) PIM1FLT3JAK2CHEK1PRKD3
SCHEMBL24716430 0.70 — —
SCHEMBL158747 0.70 F2 (0.52) LMNAHPGDALDH1A1MAPTHSD17B10
SCHEMBL29440558 0.70 F2 (0.52) LMNAHPGDALDH1A1MAPTHSD17B10
SCHEMBL30933343 0.68 HSD17B10 (0.59) PIM1FLT3JAK2CHEK1PRKD3
Methane SCHEMBL29008285 0.68 F2 (0.50) LMNAHPGDALDH1A1MAPTHSD17B10
SCHEMBL14543828 0.68 HSD17B10 (0.59) PIM1FLT3JAK2CHEK1PRKD3
SCHEMBL26124848 0.68 DAO (0.53) PIM1FLT3JAK2CHEK1PRKD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015065338-A1 QUINAZOLINE BASED RESPIRATORY SYNCYTIAL VIRUS INHIBITORS MEDIVIR AB (SE) 2015-05-07 — — WO disclosed
Send feedback